Condition: Metformin · Aging · Sponsor: Xuanwu Hospital, Beijing
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
This description comes directly from the study's public registry record.
Lingling Geng · 18510932169 · gengll@xwhosp.org
Gele Qu · 13601310067 · qugeyue@xwhosp.org
Always discuss trial participation with your own doctor first.
| Xuanwu Hospital Capital Medical University | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06459310